FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

HEIDELBERG

199.5
+10.15 (5.36%)
Updated 03:29 22/10 IST

HEIDELBERG Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for HEIDELBERG
Disclaimer
0% Bullish
0% Bearish

HEIDELBERG Buy or Sell - Brokerage Reports

No. of reports in last year
3
No. of analysts
1
Average Consensus Forecast
207
Consensus Potential
8.24%
See HEIDELBERG Share Price Targets >>

HEIDELBERG Ratings

Long term HEIDELBERG rating by FrontPage users
4.3/5 (4 Ratings)
Find answers to all your questions on live HEIDELBERG message board: Is HEIDELBERG buy or sell? Should I buy HEIDELBERG shares? Why are HEIDELBERG shares falling? Should I invest in HEIDELBERG stock?

  1. Home
  2. HEIDELBERG Forum

HEIDELBERG Share Price Discussion

P
Reputation: 3,286 • Oct 11 3:57 AM

HEIDELBERG - 1451303
#HEIDELBERG WEEKLY CHART VIEW!!

Heidelberg Cement India Ltd. closed below previous week high.
Technical indicators are mild bullish.
If price trades below weekly low 186 near by support is mid bollinger band 181.65 and 174 resistance is 203 on weekly chart.
Like
Reply
P
Reputation: 3,286 • Oct 11 3:54 AM

POLYCAB - 1451302
#POLYCAB DAILY CHART VIEW!!

Polycab India Ltd. is trading below mid bollinger band.
Technical indicators are bearish.
Near by support is 798.
If price closes below 798 level near by support is 762 and if price closes above mid bollinger band 842 next resistance is 910 on daily...
Read more...
Like
Reply
N
Reputation: 111 • Oct 11 3:50 AM

RAYMOND - 1451301
#RAYMOND Still we are in the triangle and i am expecting it has to reach for the wave v) positional target to 160 and will buy(not blindly) for a long term investment
Like
Reply
P
Reputation: 3,286 • Oct 11 3:49 AM

THOMASCOOK - 1451298
#THOMASCOOK WEEKLY CHART VIEW!!

The stock price gave a breakdown and now testing the trendline in the weekly time frame.
Technical parameters are flattish, where RSI is below 40 in weekly time frame.
26.65 -30.55 should be considered as support and resistance respectively.
Like
Reply

BEPL - Q2 FY21 (UnAudited –Cons)
CMP: 97
Total revenue from operations 308.1 Cr
279.5 Cr (10.41%) YoY | 99.4 Cr (209.21%) QoQ
Half yearly revenue: 407.2 Cr Vs. 592.9 Cr (-31.24%)
Net Profit of 35.5 Cr
20.3 Cr (75.12%) YoY (1.4) Cr (243.21%) QoQ
Hal...
Read more...
Like
Reply
M
Reputation: -1,008 • Oct 11 3:42 AM

(FREE call for the day)

Stock No. 5 for 12-Oct-20

Risky! #ITC: Quantity: 3200

BUY above: 168.3
SL: 166
Target: 168.9 / 170.6 / 172.3 / 173.9 and multiples of 0.5%

&

SELL below: 166.3
SL: 169
Target: 165.7 / 164.1 / 162.4 / 160.7 and multiples of 0.5%

*All levels are for ...
Read more...
Like
Reply
M
Reputation: -1,008 • Oct 11 3:39 AM
Like
Reply
Like
Reply
P
Reputation: 3,286 • Oct 11 3:37 AM

GARFIBRES - 1451290
#GARFIBRES WEEKLY CHART VIEW!

Shooting star formation clearly visible on the top of the current up trend.
Technical parameter are positive and strong.

2090-2250 should consider as support and resistance range.
Weakness below 2085 can try to test 2050-2030-2025 on the lower ...
Read more...
1
Reply
Like
Reply

Trend changing day for #TCS is Oct 12
Like
Reply
N
Reputation: 111 • Oct 11 3:33 AM

GRASIM - 1451285
#GRASIM Waiting for a 3 wave structure as a correction and then to z) wave to 825 for my target?
Like
Reply
N
Reputation: 111 • Oct 11 3:32 AM

TITAN - 1451284
#TITAN Target achieved as per my previous trade plan and now we have to wait for the 3 wave structure as a correction then will inform laterzzz
Like
Reply
P
Reputation: 3,286 • Oct 11 3:32 AM

BIRLACORPN - 1451283
#BIRLACORPN WEEKLY CHART VIEW!!

Birla Corporation Ltd. bounced from the weekly support zone.
It is likely to stay positive until it stays above 580-600 zone.
Technical parameters looks neutral as of now.

Keep a watch
2
Reply
N
Reputation: 6,656 • Oct 11 3:31 AM
Inhaled vaccines aim to fight Coronavirus at its point of attack
Most vaccines in human testing require two shots for effectiveness, and developers still arent even sure if theyll prevent infections. Scientists are hoping to generate superior immune responses with inhaled vaccines that directly target the airway cells the virus invades.
The Economic Times
Like
Reply
P
Reputation: 3,286 • Oct 11 3:29 AM

RATNAMANI - 1451276
#RATNAMANI WEEKLY CHART VIEW!!

Their is no major change witnessed in the overall trading sentiment.
Price is trading with in rising channel.
As of now 1310 - 1335-1350 should be considered as resistances, where as 1223- 1210 - 1200 - 1175 are standing as supports.
2
Reply
Infibeam Avenues inks definitive agreement with second largest bank of Oman
Infibeam Avenues share price added 3 per cent during the early trading session on Friday after the company entered into a definitive agreement with Oman's second-largest bank i.e. Bank Dhofar to offer its acquiring processor services to the bank. Under the agreement, Infibeam Avenues, through its digital payment solution, CCAvenue Payment Gateway Service (ePGS), will process online card transactions of various payment networks for Bank Dhofar and help the bank to authorise online...
Dalal Street Investment Journal
2
Reply
Tata Steel records highest quarterly deliveries
On Friday, Tata Steel, an Indian multinational steel-making company, announced its second-quarter key production and delivery volumes via a press filing. The company recorded the highest quarterly deliveries of 5.05 million tonnes in India, suggesting a pickup in demand for steel. Reacting to the news, the share rose nearly 3 per cent during the early trading session on Friday. The economic activity is resuming with gradual relaxations in the lockdown measures during Q2FY21. Following...
Dalal Street Investment Journal
1
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • HEIDELBERG - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,099.56
    Enterprise Value4,153.89
    Price to Earnings24.25
    Price to Book Value3.5
    Return on Capital Employed0.17
    Return on Equity0.13
    Face Value10
    Dividend Yield0.02
  • HEIDELBERG - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    24-Jul-20Prabhudas LilladherAccumulate191
    14-Feb-20Prabhudas LilladherHold215
    31-Oct-19Prabhudas LilladherAccumulate215
    2-Aug-19Elara CapitalAccumulate245
    1-Aug-19Prabhudas LilladherAccumulate220
    HEIDELBERG Brokerage Price Target
  • HEIDELBERG Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Oct 22190199.9189197.4
    Oct 21189.4190.3186.5189.35
    Oct 20187.5192.5187.1187.75
    Oct 19184.7187.8184185.35
    Oct 16185185.75181.9182.95
  • HEIDELBERG Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹185.77
    30 Day Moving Average₹185.55
    50 Day Moving Average₹187.19
    100 Day Moving Average₹182.38
    200 Day Moving Average₹177.1
  • HEIDELBERG - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,8661,717.460.09
    Operating Profit364278.860.31
    Profit Before Tax208113.630.83
    Net Income13376.210.75
  • HEIDELBERG - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,1721,0470.12
    Total Liabilities1,5251,713-0.11
    Total Assets2,6962,760-0.02
  • HEIDELBERG - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity385361.40.07
    Cash from Investing Activity-14-40.24-0.65
    Cash from Financing Activity-173-314.73-0.45
    Net Cash Flow1986.4329.79
  • HEIDELBERG - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.03
    Return on Equity0.130.08
    Return on Capital Employed0.170.12
  • HEIDELBERG - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.09
    3 Year CAGR Growth in Operating Profit0.13
    3 Year CAGR Growth in EBIDTA-0.04
    3 Year CAGR Growth in Net Income1.23
    3 Yr CAGR Growth - Diluted EPS1.23
  • HEIDELBERG - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.15
    5 Year CAGR Growth in Operating Profit3.75
    5 Year CAGR Growth in EBIDTA3.8
    5 Year CAGR Growth in Net Income3.31
    3 Yr CAGR Growth - Diluted EPS3.32
  • HEIDELBERG - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 9 3:11 AM
    Midcap cement cos could do better than largecaps going forward
    The Economic Times
    NewsBot
    Oct 7 6:06 AM
    Buy Heidelberg Cement India, target price Rs 205: ICICI Direct
    The Economic Times
    NewsBot
    Sep 29 5:36 AM
    Buy Heidelberg Cement India, target price Rs 230: ICICI Securities
    The Economic Times
    NewsBot
    Jul 31 7:13 AM
    Buy Heidelberg Cements India; target of Rs 200: Cholamandalam securities
    Moneycontrol
    NewsBot
    Jul 30 11:23 AM
    Buy Heidelberg Cement; target of Rs 231: Anand Rathi
    Moneycontrol
    NewsBot
    Jul 26 7:33 AM
    Accumulate Heidelberg Cement India; target of Rs 191: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Jul 22 12:03 PM
    HeidelbergCement India Q1 net falls 38% to Rs 49 crore
    Moneycontrol
    NewsBot
    Jun 25 10:11 AM
    Cement prices will remain high for cos to break even: Heidelberg Cement
    The Economic Times
    NewsBot
    Jun 7 2:28 AM
    Buy Heidelberg Cement; target of Rs 207: Anand Rathi
    Moneycontrol
    NewsBot
    Jun 5 7:16 AM
    Buy Heidelberg Cement, target price Rs 207: Anand Rathi
    The Economic Times
  • HEIDELBERG - Related Communities

    keyboard_arrow_down
    Grasim Industries Ltd. NSE: GRASIM | ...
    ACC Ltd. NSE: ACC | BSE: 500410 | ISI...
    Ambuja Cements Ltd. NSE: AMBUJACEM | ...
    UltraTech Cement Ltd. NSE: ULTRACEMCO...
    The India Cements Ltd. NSE: INDIACEM ...
    The Ramco Cements Ltd. NSE: RAMCOCEM ...
    Rain Industries Ltd. NSE: RAIN | BSE:...
    SHREE CEMENT Ltd. NSE: SHREECEM | BSE...
    JK Cement Ltd. NSE: JKCEMENT | BSE: 5...
    Birla Corporation Ltd. NSE: BIRLACORP...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020